SORRENTO THERAPEUTICS INC

SORRENTO THERAPEUTICS INC (SRNE) has a valuation score of 55/100 (moderate), profitability score of 32/100 (weak), financial health score of 40/100 (weak), Piotroski F-Score of 4/9, Altman Z-Score of -4.68 (distressed), revenue growth of +26.0% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 2, 2026

Analyst Recommendations7 analysts · 2023-11-01
2
4
Strong Buy 2Buy 4Hold 1Sell 0Strong Sell 0
SORRENTO THERAPEUTICS INC (SRNE) Valuation & P/E History →SORRENTO THERAPEUTICS INC (SRNE) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →